IP Library Granted Patent US 9,732,164
Granted Patent B2
US 9,732,164 · App. 14/684,017 · Granted Aug 15, 2017

Chitosan-derivative compounds and methods of controlling microbial populations

Inventors: Shenda Baker (Upland, CA); William P. Wiesmann (Washington, DC)
Assignee: SYNEDGEN, INC.
C08B37/003A61K8/736A61K31/722A61L2/232A61L2/235A61Q11/00A61Q17/005C08L5/08A61L2202/23A61L2202/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,732,164
App. No.
14/684,017
Granted
Aug 15, 2017
Kind
B2
Abstract

The present invention is directed to chitosan-derivative compounds and structures, methods of making chitosan-derivative compounds and methods for controlling, inhibiting and enhancing microbial populations in a variety of environments. The present invention is also directed to the control, inhibition and enhancement of microbial populations in animals, particularly humans. The microbial populations include bacteria, viruses and other pathogens where control of microbial populations are a necessity. The chitosan-derivative compounds of the present invention include chitosan-arginine compounds, related chitosan-L/D unnatural amino acid compounds, chitosan-acid amine compounds, chitosan-L/D natural amino acid derivative compounds, co-derivatives of the chitosan-derivative compounds, salts of the chitosan derivative compounds, and chitosan-guanidine compounds.

Claims (29)

1. A method of making a compound of Formula (I), the method comprising:

reacting a compound of Formula (II),

with an acid, thereby providing the compound of Formula (I);

wherein m is 0.02-0.50; q is 0.50-0.01; p+q+m=1; and the compound of Formula (II) is made by a method that comprises reacting a compound of Formula (III),

with a compound of Formula (IV),

thereby providing the compound of Formula (II).

2. The method of claim 1 , wherein the acid is: hydrochloric acid, hydrofluoric acid, trifluoroacetic acid (TFA) or sulfuric acid.

3. The method of claim 1 , wherein the method proceeds for between 2 and 24 hours.

4. The method of claim 1 , wherein the compound of Formula (IV) is made by a method that comprises reacting a compound of Formula (V),

with a coupling agent, thereby providing the compound of Formula (IV).

5. The method of claim 4 , wherein the method further comprises addition of an activation reagent.

6. The method of claim 5 , wherein the activation reagent is a N-hydroxysuccinimide.

7. The method of claim 4 , wherein the coupling agent is a carbodiimide.

8. The method of claim 7 , wherein the carbodiimide is N,N′-dicyclohexylcarbodiimide (DCC), N,N′-diisopropylcarbodiimide (DIC), or N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide (EDC).

9. The method of claim 8 , wherein the method takes place in the presence of a solvent.

10. The method of claim 9 , wherein the solvent is an aqueous solution.

11. The method of claim 10 , wherein the aqueous solution is acidic.

12. The method of claim 1 , wherein the acid is an organic acid, acetic acid or hydrochloric acid.

13. The method of claim 11 , wherein the pH of the aqueous solution is ≦5.

14. The method of claim 9 , wherein the solvent is an organic solvent.

15. The method of claim 14 , wherein the organic solvent is methanol, dimethylsulfoxide or dimethylformamide.

16. A method of making a compound of Formula (I) in a single reaction vessel, the method comprising:

reacting a compound of Formula (V),

wherein m is 0.02-0.50; q is 0.50-0.01; and p+q+m=1,

with Formula (III),

in the presence of an activation reagent, a coupling agent, followed by addition of an acid, thereby providing the compound of Formula (I).

17. The method of claim 16 , wherein the compound of Formula (V) and activation agent are added to the reaction with Formula (III) before the coupling agent.

18. The method of claim 1 or 16 , wherein the compound of Formula (I) is purified by dialysis.

19. The method of claim 1 , wherein the method comprises the use of ultra-filtration, dialysis filtration (UFDF), or transverse flow filtration (TFF) in-line systems.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 20, 2023
From: SYNEDGEN, INC
To: UNITED STATES GOVERNMENT
Reel/Frame 062439/0921 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2017
From: BAKER, SHENDA M.; WIESMANN, WILLIAM P.
To: SYNEDGEN, INC.
Reel/Frame 043014/0122 →
Continuity (6)
Continuation 14153699 · Jan 13, 2014
Continuation 13324461 · Dec 13, 2011
Continuation 11657382 · Jan 24, 2007
Provisional Application 60838780 · Aug 18, 2006
Provisional Application 60810591 · Jun 2, 2006
Related Publication 20160060362A1 · Mar 3, 2016